Related Experiment Video
Updated: Aug 15, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
[Ethiopathogenetic features and course of ischemic stroke associated with COVID-19]
1Bashkir State Medical University, Ufa, Russia.
Insights
COVID-19 patients experienced more severe ischemic strokes, often with unknown causes and elevated inflammatory markers. Cardiovascular risk factors were less common, suggesting unique disease pathways requiring further investigation.
Area of Science:
- Neurology
- Infectious Diseases
- Cardiology
Context:
- The association between COVID-19 and ischemic stroke is an emerging area of clinical concern.
- Understanding the unique characteristics of stroke in COVID-19 patients is crucial for effective management.
Purpose:
- To investigate the etiopathogenetic factors and clinical course of ischemic stroke in patients with COVID-19.
- To compare stroke characteristics and risk factors between COVID-19 positive and negative ischemic stroke patients.
Summary:
- A retrospective study of 173 COVID-19 positive and 86 COVID-19 negative ischemic stroke patients revealed significant differences.
- COVID-19 patients had less frequent cardiovascular risk factors but experienced more severe strokes, with a higher prevalence of unknown subtypes (TOAST classification).
- Elevated renal-hepatic markers and C-reactive protein indicated systemic inflammation in the COVID-19 group.
Impact:
- Findings highlight that COVID-19 influences stroke severity and etiology, independent of traditional cardiovascular risk factors.
- The increased severity and distinct etiological profile in COVID-19 associated strokes necessitate tailored diagnostic and therapeutic strategies.
- Further research is warranted to elucidate the negative prognostic impact of cardiovascular disease in COVID-19 patients and optimize treatment.
Objective:
To analyze etiopathogenetic factors and course of ischemic stroke associated with new coronavirus infection (COVID-19).
Material And Methods:
A retrospective clinical study of 173 patients with ischemic stroke and COVID-19 (main group) and 86 patients with ischemic stroke without COVID-19 (comparison group) was carried out. There were no statistically significant differences in age and gender. All patients underwent standard clinical-instrumental, laboratory and neuroimaging assessments.
Results:
Compared with the comparison group, patients with COVID-19 were less likely to have cardiovascular risk factors, the difference being statistically significant. Stroke in the main group was more severe than in the comparison group. According to the TOAST classification, an unknown stroke subtype significantly predominated in the main group. Laboratory data in the main group indicated the significance of an increase in renal-hepatic markers (creatinine, aspartate aminotransferase) and systemic inflammatory response syndrome (C-reactive protein).
Conclusion:
The development of cardiovascular diseases in patients with COVID-19 is an important negative prognostic factor that requires further study to determine the optimal management strategy.
More Related Videos
09:11Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability
Published on: February 23, 2016
07:34Author Spotlight: Establishing a Reliable Distal MCA Occlusion Model in Mice for Stroke Research
Published on: December 15, 2023
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
Endocarditis II: Clinical Features of Infective Endocarditis
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Coronary Artery Disease III: Clinical Manifestations